Top Markets
Coin of the day
GeneThera, Inc. GeneThera, Inc.

GeneThera, Inc.

GTHR
Clasificación en acciones #42192
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced... GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), currently in its Stage III clinical phase, as well as mad cow and chronic wasting diseases, and common bacterial infections like E.coli and salmonella. Furthermore, GeneThera is developing a vaccine specifically targeting Mycobacterium avium subspecies paratuberculosis bacteria. Utilizing its innovative Molecular Robotic/AI Platform and a strategic therapeutic framework, the company strives to inhibit the spread of animal-borne diseases and improve control over zoonotic infectious agents. GeneThera, Inc. operates out of Westminster, Colorado.
Precio por acción
$0.0001
Última sincronización: 2025-03-10
Capitalización bursátil
$3.53K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio GeneThera, Inc. (GTHR)

Categoría

Historial del precio de la acción de GeneThera, Inc. (GTHR)
Precio más alto de cierre: $0.00 el 2025-03-01

Precio más bajo de cierre: $0.08 el 2012-09-01
Historial del precio de la acción de GeneThera, Inc. desde 2012 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2025 0.00%
2024 -98.33%
2023 -59.45%
2022 -72.05%
2021 171.98%
2020 509.15%
2019 -73.75%
2018 -28.73%
2017 63.11%
2016 -70.47%
2015 65.96%
2014 -29.35%
2013 -78.40%
2012 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.46%
KR